Verogen specializes in advanced human identification technologies, primarily through its next-generation sequencing (NGS) solutions. Their offerings extend beyond traditional DNA profiling, enabling forensic investigations to tackle complex cases with greater accuracy and detail. The company’s comprehensive NGS workflow is designed to be user-friendly, scalable, and easily integrated into existing laboratory environments. This workflow supports various applications, including the analysis of short tandem repeats (STRs), mitochondrial DNA (mtDNA), kinship assessments, and the generation of externally visible characteristics from DNA samples.

The Verogen product portfolio includes the MiSeq FGx Sequencing System, which is specifically tailored for forensic and human identification purposes, and the Universal Analysis Software that simplifies data management and analysis for users of all experience levels. Their solutions encompass every step of the sequencing process, from library preparation to data analysis, ensuring high-quality results. Additionally, Verogen provides expert support and validation plans to facilitate the implementation of their NGS workflows, reinforcing their commitment to delivering better answers for forensic and human identification challenges.

United States

Verogen is a California-based company that develops and distributes next-generation gene sequencing panels and genetic code analyzing products for the healthcare sector.

Verogen

Company Details